Open AccessRelationship between β-amyloid protein 1-42, thyroid hormone levels and the risk of cognitive impairment after ischemic stroke
Author(s) -
Limin Mao,
Xiaohan Chen,
Jianhua Zhuang,
Peng Li,
Yingbin Xu,
Yuchen Zhao,
Yue-Jin Ma,
Bin He,
You Yin
Publication year - 2020
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v8.i1.76
Subject(s) - medicine , hormone , triiodothyronine , stroke (engine) , thyroid , thyroid stimulating hormone , cognition , psychiatry , mechanical engineering , engineering
Post-stroke cognitive impairment (PSCI) is not only a common consequence of stroke but also an important factor for adverse prognosis of patients. Biochemical indicators such as blood lipids and blood pressure are affected by many factors, and the ability of evaluating the progress of patients with PSCI is insufficient. Therefore, it is necessary to find sensitive markers for predicting the progress of patients and avoiding PSCI. Recent studies have shown that β-amyloid protein 1-42 (Aβ1-42) and thyroid hormone levels are closely related to PSCI, which may be the influencing factors of PSCI, but there are few related studies.